|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 239/42 | |
| C07D 401/12 | |||
| A61K 31/506 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2675794 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12705384.1 |
| Europos patento paraiškos padavimo data | 2012-02-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-12-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-02-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2012/000176 |
| Data | 2012-02-17 |
| (87) | Numeris | WO 2012/110774 |
| Data | 2012-08-23 |
| (30) | Numeris | Data | Šalis |
| 201161443773 P | 2011-02-17 | US | |
| 201161523489 P | 2011-08-15 | US | |
| 201161579729 P | 2011-12-23 | US |
| (72) |
HOLMES, Ian, Peter, AU
BERGMAN, Ylva, AU
LUNNISS, Gillian Elizabeth, AU
NIKAC, Marica, AU
CHOI, Neil, AU
HEMLEY, Catherine Fae, AU
WALKER, Scott Raymond, AU
FOITZIK, Richard Charles, AU
GANAME, Danny, AU
LESSENE, Romina, AU
|
| (73) |
Cancer Therapeutics CRC Pty Limited,
4 Research Avenue, Bundoora, VIC 3083,
AU
|
| (54) | SELECTIVE FAK INHIBITORS |
| SELECTIVE FAK INHIBITORS |